TY - JOUR
AU - 
TI - The TRITON clinical trial programme: Evaluation of the PARP inhibitor rucaparib in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD)
JO - Annals of Oncology
DO - 10.1093/annonc/mdx370.053
DA - 2017-09-01
UR - https://www.deepdyve.com/lp/unpaywall/the-triton-clinical-trial-programme-evaluation-of-the-parp-inhibitor-gDfoxwRWo3
DP - DeepDyve
ER -